Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.060
+0.020 (0.50%)
May 28, 2026, 3:24 PM EDT - Market open
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $149.87 million as of May 28, 2026. Its market cap has decreased by -0.92% in one year.
Market Cap
149.87M
Enterprise Value
53.95M
1-Year Change
-0.92%
Ranking
Category
Stock Price
$4.06
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $149.87M, a decrease of -74.83%. That is a compound annual growth rate of -15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 149.87M | -6.41% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 164.37M |
| Oramed Pharmaceuticals | 162.89M |
| Jyong Biotech | 160.34M |
| NRx Pharmaceuticals | 154.92M |
| Turn Therapeutics | 154.90M |
| TuHURA Biosciences | 151.56M |
| Indaptus Therapeutics | 143.82M |
| Agenus | 141.65M |